\[1\]HAAS H,PANULA P.The role of histamine and the tuberomamillary nucleus in the nervous system \
[J\].Nat Rev Neurosci，2003,4(2):121-130.
\[2\]ADACHI N.Cerebral ischemia and brain histamine \[J\].Brain Res Brain Res Rev，2005,50(2):275-286.
\[3\]ARRANG J M，GARBARG M,SCHWARTZ J C.Auto-inhibition of brain histamine release mediated by a novel class H3 of histamine receptor \[J\].Nature，1983,302(5911):832-837.
\[4\]LEURS R,BAKKER R A，TIMMERMAN H，et al.The histamine H3 receptor:from gene cloning to H3 receptor drugs \[J\].Nat Rev Drug Discov，2005,4(2):107-120.
\[5\]LEURS R，BLANDINA P，TEDFORD C，et al.Therapeutic potential of histamine H3 receptor agonists and antagonists \[J\].Trends Pharmacol Sci，1998,19(5):177-183.
\[6\]LINNEY I D，BUCK I M，HARPER E A，et al.Design，synthesis，and structure-activity relationships of novel non-imidazole histamine H3 receptor antagonists \[J\].J Med Chem，2000,43(12):2362-2370.
\[7\]LEURS R，TULP M T，MENGE W M，et al.Evaluation of the receptor selectivity of the H3 receptor antagonists，iodophenpropit and thioperamide:an interaction with the 5-HT3 receptor revealed \
[J\].Br J Pharmacol，1995,116(4):2315-2321.
\[8\]HARPER E A，SHANKLEY N P,BLACK J W.Characterization of the binding of \
[3H\]-clobenpropit to histamine H3-receptors in guinea-pig cerebral cortex membranes \
[J\].Br J Pharmacol，1999,128(4):881-890.
\[9\]CHEN Z，SAKURAI E，HU W，et al.Pharma-cological effects of carcinine on histaminergic neurons in the brain \[J\].Br J Pharmacol，2004,143(5):573-580.
\[10\]DRUTEL G，PEITSARO N，KARLSTEDT K，et al.Identification of rat H3 receptor isoforms with different brain expression and signaling properties \[J\].Mol Pharmacol，2001,59(1):1-8.
\[11\]HANCOCK A A，ESBENSHADE T A，KRUEGER K M，et al.Genetic and pharmacological aspects of histamine H3 receptor heterogeneity \[J\].Life Sci，2003,73(24):3043-3072.\
[12\]BAKKER R A，LOZADA A F，VAN MARLE A，et al.Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms \[J\].Mol Pharmacol，2006,69(4):1194-1206.
\[13\]WIELAND K，BONGERS G，YAMAMOTO Y，et al.Constitutive activity of histamine H3receptors stably expressed in SK-N-MC cells:display of agonism and inverse agonism by H3antagonists \
[J\].J Pharmacol Exp Ther，2001,299(3):908-914.
\[14\]GIOVANNINI M G，EFOUDEBE M，PASSANI M B，et al.Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells \
[J\].J Neurosci，2003,23(27):9016-9023.
\[15\]ROULEAU A，LIGNEAU X，TARDIVEL-LACOMBE J，et al.Histamine H3-receptor-mediated \
[35S\]GTP gamma\
[S\] binding:evidence for constitutive activity of the recombinant and native rat and human H3 receptors \
[J\].Br J Pharmacol，2002,135(2):383-392.
\[16\]SILVER R B，MACKINS C J，SMITH N C，et al.Coupling of histamine H3 receptors to neuronal Na+/H+ exchange:a novel protective mechanism in myocardial ischemia \[J\].Proc Natl Acad Sci USA，2001,98(5):2855-2859.
\[17\]SILVER R B，POONWASI K S，SEYEDI N，et al.Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings \
[J\].Proc Natl Acad Sci USA，2002,99(1):501-506.
\[18\]MOLINA-HERNANDEZ A，NUNEZ A，SIERRA J J，et al.Histamine H3 receptor activation inhibits glutamate release from rat striatal synaptosomes \
[J\].Neuropharmacology，2001,41(8):928-934.
\[19\]ESBENSHADE T A，FOX G B，KRUEGER K M，et al.Pharmacological properties of ABT-239 \
[4-(2-{2-\
[(2R)-2-Methylpyrrolidinyl\]ethyl}-benzofuran-5-yl)benzonitrile\]:I.Potent and selective histamine H3 receptor antagonist with drug-like properties \
[J\].J Pharmacol Exp Ther，2005,313(1):165-175.
\[20\]ESBENSHADE T A，KRUEGER K M，MILLER T R，et al.Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920:I.In vitro pharmacological effects \
[J\].J Pharmacol Exp Ther，2003,305(3):887-896.